Bedminster, NJ, United States of America

Abdul E Mutlib

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Hoechst Marion Roussel. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abdul E Mutlib. Retrieved from https://idiyas.com/inventor/abdul-e-mutlib

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Abdul E Mutlib: Innovator in Pharmaceutical Chemistry

Introduction

Abdul E Mutlib is a notable inventor based in Bedminster, NJ (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on substituted benzothienylpiperazines.

Latest Patents

Mutlib holds a patent for his invention titled "Substituted benzothienylpiperazines and their use." This invention relates to compounds of a specific formula, where various substituents can be halogen, hydroxy, (C1-C6)alkoxy, amino, or trifluoromethyl. The patent also details the structural variations of the compounds, showcasing Mutlib's expertise in chemical synthesis and application.

Career Highlights

Throughout his career, Abdul E Mutlib has been associated with Hoechst Marion Roussel, a prominent company in the pharmaceutical industry. His work has contributed to advancements in drug development and therapeutic applications.

Collaborations

Mutlib has collaborated with esteemed colleagues, including Nicholas J Hrib and John G Jurcak. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Abdul E Mutlib's contributions to pharmaceutical chemistry through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…